Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atara Biotherapeutics (ATRA) Depreciation and Depletion (2022 - 2025)

Atara Biotherapeutics filings provide 4 years of Depreciation and Depletion readings, the most recent being $100000.0 for Q4 2025.

  • On a quarterly basis, Depreciation and Depletion fell 80.0% to $100000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $400000.0, a 85.19% decrease, with the full-year FY2025 number at $400000.0, down 85.19% from a year prior.
  • Depreciation and Depletion hit $100000.0 in Q4 2025 for Atara Biotherapeutics, down from $300000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $1.5 million in Q1 2022 to a low of $100000.0 in Q4 2025.
  • Median Depreciation and Depletion over the past 4 years was $900000.0 (2022), compared with a mean of $828571.4.
  • Biggest five-year swings in Depreciation and Depletion: changed 0.0% in 2023 and later crashed 80.0% in 2025.
  • Atara Biotherapeutics' Depreciation and Depletion stood at $900000.0 in 2022, then changed by 0.0% to $900000.0 in 2023, then plummeted by 44.44% to $500000.0 in 2024, then crashed by 80.0% to $100000.0 in 2025.
  • The last three reported values for Depreciation and Depletion were $100000.0 (Q4 2025), $300000.0 (Q1 2025), and $500000.0 (Q4 2024) per Business Quant data.